-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Star Enterprise of Chemical Machinery and Equipment Network ] Looking back at July 2021, with the acceleration of fixed asset investment in pharmaceutical companies and the high boom in the biopharmaceutical industry , the pharmaceutical equipment industry is facing new opportunities and challenges
.
Within this month, a group of pharmaceutical machinery companies issued announcements on the pre-increase of performance for the first half of 2021.
Some pharmaceutical machinery companies have frequently received institutional investigations, and there have been personnel changes within the company within a month.
.
.
The dynamics of many pharmaceutical machinery companies have demonstrated the full industry.
Vitality and potential
.
The author sorted out the major events that occurred in the pharmaceutical equipment industry in July 2021, let's take a look
.
Chemical machinery equipment network star enterprise chemical machinery equipment pharmaceutical equipment.
Within this month, a group of pharmaceutical machinery companies issued announcements on the pre-increase of performance for the first half of 2021.
Some pharmaceutical machinery companies have frequently received institutional investigations, and there have been personnel changes within the company within a month.
.
.
The dynamics of many pharmaceutical machinery companies have demonstrated the full industry.
Vitality and potential
.
The author sorted out the major events that occurred in the pharmaceutical equipment industry in July 2021, let's take a look
.
Policy dynamics
Policy dynamicsOn July 2, the Ministry of Industry and Information Technology issued the "Six Departments' Guiding Opinions on Accelerating the Cultivation and Development of High-Quality Manufacturing Enterprises", proposing opinions on accelerating the cultivation and development of high-quality manufacturing enterprises from 10 aspects, in order to stimulate the vitality of market players and promote the high-quality development of manufacturing
.
In addition, since July, many places including Shanghai, Zhejiang and other places have successively disclosed the "14th Five-Year" plan for the manufacturing industry, and have clarified the key development directions for the next five years
.
As an important part of the manufacturing industry, the pharmaceutical equipment industry will also be affected by a series of favorable policies to accelerate the pace of industrial innovation and development
.
.
In addition, since July, many places including Shanghai, Zhejiang and other places have successively disclosed the "14th Five-Year" plan for the manufacturing industry, and have clarified the key development directions for the next five years
.
As an important part of the manufacturing industry, the pharmaceutical equipment industry will also be affected by a series of favorable policies to accelerate the pace of industrial innovation and development
.
Industry dynamics
Industry dynamicsIn July, it was the concentration period when listed companies in the pharmaceutical machinery industry disclosed their annual reports for the first half of the year.
As a whole, the performance of the pharmaceutical machinery industry companies in the first half of the year was positive
.
For example, on July 14, 2021, Canaan Technology released the 2021 semi-annual performance forecast.
The net profit attributable to shareholders of listed companies during the reporting period is expected to be 36.
6704 million yuan to 45.
132 million yuan, an increase of 30%-60% over the same period of the previous year.
; On July 6, Tofflon disclosed the 2021 semi-annual performance forecast, with a profit of 310 million-344 million yuan, an increase of 80% -100% over the same period of the previous year; on July 3, Xinlai Yingcai disclosed the first half of 2021 The annual performance forecast is expected to increase in the same direction
.
During the reporting period, the net profit attributable to shareholders of listed companies was RMB 58 million to RMB 68 million, an increase of 71.
82%-101.
44% over the same period in 2020
.
As a whole, the performance of the pharmaceutical machinery industry companies in the first half of the year was positive
.
For example, on July 14, 2021, Canaan Technology released the 2021 semi-annual performance forecast.
The net profit attributable to shareholders of listed companies during the reporting period is expected to be 36.
6704 million yuan to 45.
132 million yuan, an increase of 30%-60% over the same period of the previous year.
; On July 6, Tofflon disclosed the 2021 semi-annual performance forecast, with a profit of 310 million-344 million yuan, an increase of 80% -100% over the same period of the previous year; on July 3, Xinlai Yingcai disclosed the first half of 2021 The annual performance forecast is expected to increase in the same direction
.
During the reporting period, the net profit attributable to shareholders of listed companies was RMB 58 million to RMB 68 million, an increase of 71.
82%-101.
44% over the same period in 2020
.
Regarding the reasons for the performance growth in the first half of the year, many companies attributed the company's sales revenue to the stable growth in the first half of the year.
Among them, Canaan Technology mentioned that the downstream pharmaceutical industry demand was relatively strong during the reporting period, which led to the rapid growth of project orders
.
Tofflon said that the company's bioengineering business and medical equipment business have developed rapidly, and new products have been continuously launched into the market, which have been widely recognized by customers, and their operating performance has risen rapidly
.
Among them, Canaan Technology mentioned that the downstream pharmaceutical industry demand was relatively strong during the reporting period, which led to the rapid growth of project orders
.
Tofflon said that the company's bioengineering business and medical equipment business have developed rapidly, and new products have been continuously launched into the market, which have been widely recognized by customers, and their operating performance has risen rapidly
.
In addition, thanks to the acceleration of fixed asset investment by pharmaceutical companies and the high boom in the biopharmaceutical industry, the entire pharmaceutical equipment industry has ushered in a business cycle.
Many pharmaceutical machinery companies still received institutional attention in July
.
For example, Chutian Technology released three pieces of survey activity information in a row in July this year.
The company accepted institutional surveys on July 19, July 13, and July 20.
The number of surveyed institutions reached 4 and 8 respectively.
, 2 companies
.
Many pharmaceutical machinery companies still received institutional attention in July
.
For example, Chutian Technology released three pieces of survey activity information in a row in July this year.
The company accepted institutional surveys on July 19, July 13, and July 20.
The number of surveyed institutions reached 4 and 8 respectively.
, 2 companies
.
Personnel changes
Personnel changes Pharmaceutical equipment is an industry that integrates machine, electricity, gas, and light, and computer technology.
It has high requirements for talents.
It needs compound talents who understand equipment and pharmaceutical technology, and have experience in the industry
.
In terms of management, there is also a need for high-level management that matches the development of the enterprise
.
It has high requirements for talents.
It needs compound talents who understand equipment and pharmaceutical technology, and have experience in the industry
.
In terms of management, there is also a need for high-level management that matches the development of the enterprise
.
On July 17, Canaan Technology issued the "Announcement on the Appointment of the Company's Honorary Chairman".
The announcement showed that due to the renewal of the board of directors, Mr.
Fang Hengzhi will no longer serve as the company's director from the fifth board of directors on July 16, 2021
.
At the same time, after discussion and research by the company's board of directors, it was agreed to appoint Mr.
Fang Hengzhi as the honorary chairman of the company's board of directors
.
After that, Mr.
Fang Hengzhi will assist the company to continue to strengthen its strategic development planning and strategic resource coordination, and to provide guidance and assistance to the company in promoting the inheritance and development of corporate culture, so as to achieve long-term sustainable, stable and high-quality development of the company.
Repay company shareholders and society with better performance
.
The announcement showed that due to the renewal of the board of directors, Mr.
Fang Hengzhi will no longer serve as the company's director from the fifth board of directors on July 16, 2021
.
At the same time, after discussion and research by the company's board of directors, it was agreed to appoint Mr.
Fang Hengzhi as the honorary chairman of the company's board of directors
.
After that, Mr.
Fang Hengzhi will assist the company to continue to strengthen its strategic development planning and strategic resource coordination, and to provide guidance and assistance to the company in promoting the inheritance and development of corporate culture, so as to achieve long-term sustainable, stable and high-quality development of the company.
Repay company shareholders and society with better performance
.
Original title: Looking back on July, what are the major events in the pharmaceutical industry?
